EXTROVIS
P V Raghavendra Rao is currently serving as the Group CFO at EXTROVIS, an investment firm based in Hyderabad, with a focus on overseeing the group's pharmaceutical investments since October 2023. Prior to this role, Raghavendra held the position of Chief Financial Officer at Sequent Scientific Limited from July 2022 to October 2023 and at MACLEODS PHARMACEUTICALS LTD. for a period from September 2021 to July 2022. Raghavendra's extensive experience at Dr. Reddy's Laboratories spanned from July 2007 to August 2021, during which time multiple finance leadership roles were undertaken, including BU Finance Head for PSAI and RoW Finance Head. Raghavendra began a career at New Holland Tractors from September 2002 to August 2007 as a Finance Professional and previously served as Senior Accounts Officer at Indo Asian Fusegear Limited from September 2000 to September 2002. Raghavendra is a Chartered Accountant.
This person is not in any offices
EXTROVIS
Extrovis is a fully integrated global pharmaceutical company with strong portfolio offering, comprising of Active Pharmaceutical Ingredients (APIs), Finished dosage forms (FDF) & Custom Pharmaceutical Services. Based in Switzerland, with global presence in North America, India and South America, we are supported by strong network to deliver products across geographies. Our state-of-the-art manufacturing facilities and R&D centers comply with highest international quality standards with accreditions from the USFDA, PMDA, EU and other global regulatory bodies. Our contributions in the area of education and health to financially under privileged reinforces our social commitment. Our mission is to become a reliable partner by offering high quality APIs, FDFs, custom pharmaceutical services and delivering value to our customers, stake holders and patients. Backed by our EXTROrdinary VISion, we have our eyes set on becoming a leading pharmaceutical company in the world.